Evidence map›Paper›PMID 35756504›Full record

ArticleChemical science2022

The quantum dot

Chloé Grazon, Margaret Chern, Patrick Lally, R C Baer, Andy Fan, Sébastien Lecommandoux, Catherine Klapperich, Allison M Dennis, James E Galagan, Mark W Grinstaff

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Methods for Conjugating Antibodies with Quantum Dots.Molecules (Basel, Switzerland) · 2025
    Review
  4. Inter-Nanoparticle FRET for Biosensing: Photophysics Versus Size.Angewandte Chemie (International ed. in English) · 2025
    Review
  5. Review
  6. Review
  7. Review of FRET biosensing and its application in biomolecular detection.American journal of translational research · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Chloé GrazonDepartment of Chemistry, Boston University Boston MA 02215 USA chloe.grazon@u-bordeaux.fr mgrin@bu.edu.ORCID https://orcid.org/0000-0002-4564-8738
Margaret ChernDivision of Materials Science and Engineering, Boston University Boston MA 02215 USA margaret.chern@gmail.com aldennis@bu.edu.ORCID https://orcid.org/0000-0003-3993-5500
Patrick LallyDepartment of Biomedical Engineering, Boston University Boston MA 02215 USA plally@bu.edu canvasback@gmail.com catherin@bu.edu.
R C BaerDepartment of Microbiology, Boston University Boston MA 02118 USA rcbaer@gmail.com jgalag@bu.edu.ORCID https://orcid.org/0000-0001-8512-6160
Andy FanDepartment of Biomedical Engineering, Boston University Boston MA 02215 USA plally@bu.edu canvasback@gmail.com catherin@bu.edu.ORCID https://orcid.org/0000-0002-4898-3531
Sébastien LecommandouxUniversity Bordeaux, CNRS, Bordeaux INP, LCPO, UMR 5629 F-33600 Pessac France sebastien.lecommandoux@enscbp.fr.ORCID https://orcid.org/0000-0003-0465-8603
Catherine KlapperichDepartment of Biomedical Engineering, Boston University Boston MA 02215 USA plally@bu.edu canvasback@gmail.com catherin@bu.edu.ORCID https://orcid.org/0000-0001-6103-849X
Allison M DennisDivision of Materials Science and Engineering, Boston University Boston MA 02215 USA margaret.chern@gmail.com aldennis@bu.edu.ORCID https://orcid.org/0000-0001-5759-9905
James E GalaganDepartment of Microbiology, Boston University Boston MA 02118 USA rcbaer@gmail.com jgalag@bu.edu.ORCID https://orcid.org/0000-0003-0542-3291
Mark W GrinstaffDepartment of Chemistry, Boston University Boston MA 02215 USA chloe.grazon@u-bordeaux.fr mgrin@bu.edu.ORCID https://orcid.org/0000-0002-5453-3668
Boston University · USCentre National de la Recherche Scientifique · FR

Funding

Center for Innovation in Point of Care Technologies for the Future of Cancer CareU54EB015403 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI KLAPPERICH, CATHERINE M. · 2012 to 2016
$8.9M
Institutional Career DevelopmentKL2TR001411 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MORONE, NATALIA E. · 2015 to 2024
$5.9M
Novel Biosensors based on Mining Bacterial Transcription FactorsR01EB029795 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI GALAGAN, JAMES E, KLAPPERICH, CATHERINE M. · 2020 to 2024
$2.6M
Multiplexed Imaging in the Near Infrared with Indium Phosphide Quantum ShellsR01GM129437 · NIGMS · NORTHEASTERN UNIVERSITY · PI DENNIS, ALLISON MARIE · 2019 to 2022
$2.1M
Advanced laser scanning confocal microscope for multiple usersS10OD024993 · OD · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI MERTZ, JEROME · 2018 to 2018
$448k
NCATS NIH HHS KL2 TR001411NIBIB NIH HHS R01 EB029795NIBIB NIH HHS U54 EB015403NIGMS NIH HHS R01 GM129437NIH HHS S10 OD024993
6 · The paper itself

Abstract

Förster resonance energy transfer (FRET) is a widely used and ideal transduction modality for fluorescent based biosensors as it offers high signal to noise with a visibly detectable signal. While intense efforts are ongoing to improve the limit of detection and dynamic range of biosensors based on biomolecule optimization, the selection of and relative location of the dye remains understudied. Herein, we describe a combined experimental and computational study to systematically compare the nature of the dye,

Identifiers

PMID35756504
PMCPMC9172442
OpenAlexW4281761533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.